Journal Home > Volume 13 , Issue 1

Active ingredients from highland barley have received considerable attention as natural products for developing treatments and dietary supplements against obesity. In practical application, the research of food combinations is more significant than a specific food component. This study investigated the lipid-lowering effect of highland barley polyphenols via lipase assay in vitro and HepG2 cells induced by oleic acid (OA). Five indexes, triglyceride (TG), total cholesterol (T-CHO), low density lipoprotein-cholesterol (LDL-C), aspartate aminotransferase (AST), and alanine aminotransferase (ALT), were used to evaluate the lipid-lowering effect of highland barley extract. We also preliminary studied the lipid-lowering mechanism by Real-time fluorescent quantitative polymerase chain reaction (qPCR). The results indicated that highland barley extract contains many components with lipid-lowering effects, such as hyperoside and scoparone. In vitro, the lipase assay showed an 18.4% lipase inhibition rate when the additive contents of highland barley extract were 100 μg/mL. The intracellular lipid-lowering effect of highland barley extract was examined using 0.25 mmol/L OA-induced HepG2 cells. The results showed that intracellular TG, LDL-C, and T-CHO content decreased by 34.4%, 51.2%, and 18.4%, respectively. ALT and AST decreased by 51.6% and 20.7% compared with the untreated hyperlipidemic HepG2 cells. qPCR results showed that highland barley polyphenols could up-regulation the expression of lipid metabolism-related genes such as PPARγ and Fabp4.


menu
Abstract
Full text
Outline
About this article

Evaluation of the intracellular lipid-lowering effect of polyphenols extract from highland barley in HepG2 cells

Show Author's information Yijun Yao,Zhifang LiBowen QinXingrong JuLifeng Wang( )
College of Food Science and Engineering/ Collaborative Innovation Centre for Modern Grain Circulation and Safety, Nanjing University of Finance and Economics, Nanjing 210023, China

Peer review under responsibility of Tsinghua University Press.

Highlights

1. In vitro, lipase assay showed that the inhibition rate of lipase reached 18.4% after adding highland barley extracts.

2. The content of intracellular TG, LDL-C, T-CHO, ALT and AST were decreased by 34.4%, 51.2%, 18.4%, 51.6% and 20.7% after highland barley extracts treatment.

3. Highland barley extract could up-regulation the expression of lipid metabolism related genes such as PPARγ and Fabp4.

Abstract

Active ingredients from highland barley have received considerable attention as natural products for developing treatments and dietary supplements against obesity. In practical application, the research of food combinations is more significant than a specific food component. This study investigated the lipid-lowering effect of highland barley polyphenols via lipase assay in vitro and HepG2 cells induced by oleic acid (OA). Five indexes, triglyceride (TG), total cholesterol (T-CHO), low density lipoprotein-cholesterol (LDL-C), aspartate aminotransferase (AST), and alanine aminotransferase (ALT), were used to evaluate the lipid-lowering effect of highland barley extract. We also preliminary studied the lipid-lowering mechanism by Real-time fluorescent quantitative polymerase chain reaction (qPCR). The results indicated that highland barley extract contains many components with lipid-lowering effects, such as hyperoside and scoparone. In vitro, the lipase assay showed an 18.4% lipase inhibition rate when the additive contents of highland barley extract were 100 μg/mL. The intracellular lipid-lowering effect of highland barley extract was examined using 0.25 mmol/L OA-induced HepG2 cells. The results showed that intracellular TG, LDL-C, and T-CHO content decreased by 34.4%, 51.2%, and 18.4%, respectively. ALT and AST decreased by 51.6% and 20.7% compared with the untreated hyperlipidemic HepG2 cells. qPCR results showed that highland barley polyphenols could up-regulation the expression of lipid metabolism-related genes such as PPARγ and Fabp4.

Keywords: HepG2 cells, Lipid-lowering effect, Highland barley, Polyphenols extract

References(46)

[1]

J.G. Fan, S.U. Kim, V.W.S. Wong, New trends on obesity and NAFLD in Asia, Journal of Hepatology 67 (2017) 862-873. https://doi.org/10.1016/j.jhep.2017.06.003.

[2]

S. Li, J. Pan, X. Hu, et al., Kaempferol inhibits the activity of pancreatic lipase and its synergistic effect with orlistat, Journal of Functional Foods 72 (2020) 104041. https://doi.org/10.1016/j.jff.2020.104041.

[3]

M.T. Ha, M.H. Tran, K.J. Ah, et al., Potential pancreatic lipase inhibitory activity of phenolic constituents from the root bark of Morus alba L, Bioorganic & Medicinal Chemistry Letters 26 (2016) 2788-2794. https://doi.org/10.1016/j.bmcl.2016.04.066.

[4]

X. Hu, F. Xu, J. Li, et al., Ultrasonic-assisted extraction of polysaccharides from coix seeds: optimization, purification, and in vitro digestibility, Food Chemistry 2022, 374: 131636. https://doi.org/10.1016/j.foodchem.2021.131636.

[5]

A.M. Heck, J.A. Yanovski, K.A. Calis, Orlistat, a new lipase inhibitor for the management of obesity, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (2000) 270-279. https://doi.org/10.1592/phco.20.4.270.34882.

[6]
T. Sharma, P. Agrawal, P. Sahoo, et al., Line segments based rotation invariant descriptor for disparate images. In 2018 IEEE applied imagery pattern recognition workshop (AIPR) (2018) (pp.1-8).IEEE. https://doi.org/10.1109/AIPR.2018.8707401.
DOI
[7]

L. Rajan, D. Palaniswamy, S.K. Mohankumar, Targeting obesity with plant-derived pancreatic lipase inhibitors: a comprehensive review.Pharmacological Research 155 (2020) 104681. https://doi.org/10.1016/j.phrs.2020.104681.

[8]

D. Sosnowska, A. Podsędek, M. Redzynia, et al., Inhibitory effect of black chokeberry fruit polyphenols on pancreatic lipase-searching for most active inhibitors, Journal of Functional Foods 49 (2018) 196-204. https://doi.org/10.1016/j.jff.2018.08.029.

[9]

H. Liu, X. Chen, D. Zhang, et al., Effects of highland barley bran extract rich in phenolic acids on the formation of Nε-carboxymethyllysine in a biscuit model, Journal of Agricultural and Food Chemistry 66 (2018) 1916-1922. https://doi.org/10.1021/acs.jafc.7b04957.

[10]

N.M. McKeown, P.F. Jacques, C.J. Seal, et al., Whole grains and health: from theory to practice-highlights of the Grains for Health Foundation’s Whole Grains Summit 2012, The Journal of Nutrition 143 (2013) 744S-758S. https://doi.org/10.3945/jn.112.172536.

[11]

H. Hu, P. Liu, P.P. Cheng, et al., Study on the auxiliary hypoglycemic function of small molecule β-glucan from Hull-less Barley, Food Research and Development 39 (2018) 33-37.

[12]

Y. Yao, H. Wang, F. Xu, et al. Insoluble-bound polyphenols of adlay seed ameliorate H2O2-induced oxidative stress in HepG2 cells via Nrf2 signalling, Food Chemistry 2020, 325: 126865. https://doi.org/10.1016/j.foodchem.2020.126865.

[13]

Y. Yao, F. Xu, X. Ju, et al., Lipid-lowering effects and intestinal transport of polyphenol extract from digested buckwheat in Caco-2/HepG2 coculture models, Journal of Agricultural and Food Chemistry 68 (2020) 4205-4214. https://doi.org/10.1021/acs.jafc.0c00321.

[14]

D. Gilham, R. Lehner, Techniques to measure lipase and esterase activity in vitro, Methods 36 (2005) 139-147. https://doi.org/10.1016/j.ymeth.2004.11.003.

[15]

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of Immunological Methods 65 (1983) 55-63. https://doi.org/10.1016/0022-1759(83)90303-4.

[16]

H. Liu, X. Chen, D. Zhang, et al., Effects of highland barley bran extract rich in phenolic acids on the formation of Nε-Carboxymethyllysine in a biscuit model, Journal of Agricultural and Food Chemistry 66 (2018) 1916-1922. https://doi.org/10.1021/acs.jafc.7b04957.

[17]

F. Xu, Y. Yao, X. Xu, et al., Identification and quantification of DPP-IVinhibitory peptides from hydrolyzed-rapeseed-protein-derived napin with analysis of the interactions between key residues and protein domains, Journal of Agricultural and Food Chemistry 2019, 67(13): 3679-3690. https://doi.org/10.1021/acs.jafc.9b01069.

[18]

S.K. Ku, W. Zhou, W. Lee, et al., Anti-inflammatory effects of hyperoside in human endothelial cells and in mice, Inflammation 38 (2015) 784-799. https://doi.org/10.1007/s10753-014-9989-8.

[19]

S. Lee, S.H. Jung, Y.S. Lee, et al., Antiinflammatory activity of hyperin from Acanthopanax chiisanensis roots, Archives of pharmacal research 27 (2004) 628-632. https://doi.org/10.1007/BF02980162.

[20]

V. Holzer, A.D. Lower-Nedza, M. Nandintsetseg, et al., Antioxidant constituents of Cotoneaster melanocarpus Lodd, Antioxidants 2 (2013) 265-272. https://doi.org/10.3390/antiox2040265.

[21]

W.Q. Wang, C.G. Ma, S.Y. Xu, Protective effect of hyperin against myocardial ischemia and reperfusion injury, Zhongguo Yao Li Xue Bao=Acta Pharmacologica Sinica 17 (1996) 341-344.

[22]

W. Xie, Z. Jiang, J. Wang, et al., Protective effect of hyperoside against acetaminophen (APAP) induced liver injury through enhancement of APAP clearance, Chemico-Biological Interactions 246 (2016) 11-19. https://doi.org/10.1016/j.cbi.2016.01.004.

[23]

E. Jang, B.J. Kim, K.T. Lee, et al., A survey of therapeutic effects of Artemisia capillaris in liver diseases, Evidence-Based Complementary and Alternative Medicine (2015). https://doi.org/10.1155/2015/728137.

[24]

Y. Wang, M. Wang, B. Chen, et al., Scoparone attenuates high glucoseinduced extracellular matrix accumulation in rat mesangial cells, European Journal of Pharmacology 815 (2017) 376-380. https://doi.org/10.1016/j.ejphar.2017.09.039.

[25]

B.R. Choi, H.K. Kim, J.K. Park, et al., Penile erection induced by scoparone from Artemisia capillaris through the nitric oxide-cyclic guanosine monophosphate signaling pathway, The World Journal of Men’s Health 35(2017) 196-204. https://doi.org/10.5534/wjmh.17023.

[26]
M. Xu, J. Cai, H. Wei, et al., Scoparone protects against pancreatic fibrosis via TGF-β/Smad signaling in rats, Cellular Physiology and Biochemistry 40 277-286. https://doi.org/10.1159/000452544.
DOI
[27]

A. Fayyaz, S. Makwinja, S. Auriola, et al., Comparison of in vitro hepatic scoparone 7-O-demethylation between humans and experimental animals, Planta Medica 84 (2018) 320-328. https://doi.org/10.1055/s-0043-119886.

[28]

C. Austin, D. Stewart, J.W. Allwood, et al., Extracts from the edible seaweed, Ascophyllum nodosum, inhibit lipase activity in vitro: contributions of phenolic and polysaccharide components, Food & Function 9 (2018) 502-510. https://doi.org/10.1039/C7FO01690E.

[29]

G.J. McDougall, N.N. Kulkarni, D. Stewart, Berry polyphenols inhibit pancreatic lipase activity in vitro, Food Chemistry 115 (2009) 193-199. https://doi.org/10.1016/j.foodchem.2008.11.093.

[30]

C. Jiang, Z. Zeng, Y. Huang, et al., Chemical compositions of Pu’er tea fermented by Eurotium cristatum and their lipid-lowering activity, LWT. 98(2018) 204-211. https://doi.org/10.1016/j.lwt.2018.08.007.

[31]

K.D. Kaur, A. Jha, L. Sabikhi, et al., Significance of coarse cereals in health and nutrition: a review, Journal of Food Science and Technology 51 (2014) 1429-1441. https://doi.org/10.1007/s13197-011-0612-9.

[32]

W.Y.W. Lee, L.C.M. Chiu, J.H.K. Yeung, Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation, Food and Chemical Toxicology 46 (2008) 328-338. https://doi.org/10.1016/j.fct.2007.08.013.

[33]

C. Chen, Y. Zhang, Y. Gao, et al., Identification and anti-tumour activities of phenolic compounds isolated from defatted adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) seed meal, Journal of Functional Foods 26 (2016) 394-405. https://doi.org/10.1016/j.jff.2016.08.016.

[34]

M.J. Tian, J.N. Song, P.P. Liu, et al., Effects of beta glucan in highland barley on blood glucose and serum lipid in high fat-induced C57 mouse, Zhonghua Yu Fang Yi Xue Za Zhi [Chinese journal of preventive medicine] 47 (2013) 55-58.

[35]

M. Ahmadian, J.M. Suh, N. Hah, et al., PPARγ signaling and metabolism: the good, the bad and the future, Nature Medicine 19 (2013) 557-566. https://doi.org/10.1038/nm.3159

[36]

R.K. Semple, V.K.K. Chatterjee, S. O’Rahilly, PPARγ and human metabolic disease, The Journal of Clinical Investigation 116 (2006) 581-589. https://doi.org/10.1172/JCI28003.

[37]

T.P. Spiegelman, Fat and beyond: the diverse biology of PPARgamma, Annu Rev Biochem 77 (2008) 289312. https://doi.org/10.1146/annurev.biochem.77.061307.091829.

[38]

X. Feng, W. Yu, X. Li, et al., Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation, Biochemical Pharmacology 136 (2017) 136-149. https://doi.org/10.1016/j.bcp.2017.04.014.

[39]

E. Krušinová, T. Pelikánová, Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?, Diabetes Research and Clinical Practice 82 (2008) S127-S134. https://doi.org/10.1016/j.diabres.2008.09.023.

[40]

A. Chmurzyńska, The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism, Journal of Applied Genetics 47 (2006) 39-48. https://doi.org/10.1007/BF03194597.

[41]

A.W. Zimmerman, J.H. Veerkamp, New insights into the structure and function of fatty acid-binding proteins, Cellular and Molecular Life Sciences CMLS 59 (2002) 1096-1116. https://doi.org/10.1007/s00018-002-8490-y.

[42]

A.R. Kimmel, D.L. Brasaemle, M. McAndrews-Hill, et al., Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins, Journal of Lipid Research 51 (2010) 468-471. https://doi.org/10.1194/jlr.R000034.

[43]

J.G. Granneman, H.P.H. Moore, R. Krishnamoorthy, et al., Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5)and adipose triglyceride lipase (Atgl), Journal of Biological Chemistry 284(2009) 34538-34544. https://doi.org/10.1074/jbc.M109.068478.

[44]

T.H.M. Grahn, Y. Zhang, M.J. Lee, et al., FSP27 and PLIN1 interaction promotes the formation of large lipid droplets in human adipocytes, Biochemical and Biophysical Research Communications 432 (2013) 296-301. https://doi.org/10.1016/j.bbrc.2013.01.113.

[45]

Y. Fu, Adiponectin signaling and metabolic syndrome, Progress in Molecular Biology and Translational Science 121 (2014) 293-319. https://doi.org/10.1016/B978-0-12-800101-1.00009-0.

[46]

I. Kharroubi, J. Rasschaert, D.L. Eizirik, et al., Expression of adiponectin receptors in pancreatic β cells, Biochemical and Biophysical Research Communications 312 (2003) 1118-1122. https://doi.org/10.1016/j.bbrc.2003.11.042.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 05 May 2022
Revised: 23 May 2022
Accepted: 05 July 2022
Published: 01 June 2023
Issue date: January 2024

Copyright

© 2024 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

Acknowledgements

This research was financially supported by the National Key Research and Development Program of China (2021YFD2100904), the National Natural Science Foundation of China (31871729, 32172147), the Modern Agriculture key Project of Jiangsu Province of China (BE2022317), the Modern Agricultural Industrial Technology System Construction Project of Jiangsu Province of China (JATS [2021] 522), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funding agencies had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the article for publication. And I would like to appreciate the musical actor Qu Yi. You have brought me hope and joy in such world that is not so good as I expected, especially in the hard period I finished this job. So thank you and wish you all well in the future.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return